However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, as Visual Capitalist's Anshool Deshmukh notes, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.